Hepatitis B vaccine - Epimmune
Alternative Names: CY 1899; Theradigm-HBV; Theradigm-Hepatitis B vaccineLatest Information Update: 17 Dec 2021
At a glance
- Originator Epimmune
- Class Hepatitis B vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hepatitis B
Most Recent Events
- 08 Sep 1999 A study has been added to the adverse events section and the Viral Infections therapeutic trials section
- 15 Jul 1999 Epimmune has been awarded a US patent covering its epitope-based vaccine technology
- 31 Dec 1997 Discontinued - Phase-II for Hepatitis B treatment in USA (unspecified route)